NCT00638872View on ClinicalTrials.gov

Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers

PHASE4CompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2011

Conditions
Diabetic UlcerFoot Ulcer Unhealed
Interventions
DRUG

Polydeoxyribonucleotide

3 times a week perilesional or intramuscular injections

OTHER

0.9% NaCl

same as PDRN

Trial Locations (1)

98125

University of Messina, Messina

All Listed Sponsors
lead

University of Messina

OTHER

NCT00638872 - Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers | Biotech Hunter | Biotech Hunter